RELATIONSHIP BETWEEN VASCULAR ENDOTHELIAL CELL INJURIES AND RED CELL FRAGMENTATION SYNDROME
RELATIONSHIP BETWEEN VASCULAR ENDOTHELIAL CELL INJURIES AND RED CELL FRAGMENTATION SYNDROME
批准号:
06671086
负责人:
WADA Hideo
金额:
$1.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995
中文摘要
红细胞碎裂综合征(RCFS)包括血栓性血小板减少性紫癜(TTP)和药物性溶血性尿毒综合征(HUS),死亡率高。血栓调节蛋白(TM)等血管内皮细胞标志物在TTP和HUS患者中显著升高,而在药物诱导的HUS患者中这些标志物略有升高,血浆中的苯乙炔水平显著升高,并且这些与临床病程密切相关。RCFS患者呈高凝、低纤溶状态,TTP患者多伴有高分子量血管性血友病因子多聚体减少和血小板活化。RCFS患者血浆组织因子途径抑制物(TFPI)水平显著降低,TTP患者血浆培养的人脐静脉内皮细胞MTT法吸光度显著降低,BrDu法DNA合成增加,趋化性降低,组织因子(TF)活性增加,提示有多种因素激活或损伤血管内皮细胞。丝裂霉素C或其衍生物可降低细胞的MTT吸光度、TF活性和趋化性。药物诱导的HUS血管内皮细胞损伤机制可能与TTP不同,多种激活或损伤可能影响RCFS的发生。
英文摘要
Red cell fragmentation syndrome (RCFS) including thrombotic thrombocytopenic purpura (TTP) and drug induced hemolytic uremic syndrome (HUS) have a high mortality. Vascular endothelial cell markers as thrombomodulin (TM) were significantly increased in patients with TTP and those with HUS,and these markers were slightly increased in patients with drug induced HUS.Plasma cytokyne levels were significantly increased and these were well correlated with clinical course. The patients with RCFS were hypercoagulableand hypofibrinolytic state, and decreased high molecular weight multimer of von Willebrand factor and activation of platelets were observed in most of TTP patients. Plasma level of tissue factor pathway inhibitor (TFPI) were significantly decreased in patients with RCFS.In human umbilical venous endothelial cell cultured with plasma of TTP patients, the absorbance of MTT assay was significantly decreased, and DNA synthesis was increased by BrDu assay, and chemotaxis was decreased, and tissue factor (TF) activity was increased, suggesting that there were several factors activating or injuring vascular endothelial cells. In thses cells cultured with mitomicin C or its derivative, the absorbance of MTT assay, TF activity, and chemotaxis reduced. The mechanism of vascular endothelial cell injuries in drug induced HUS might be different from those in TTP.Various activation or injuries might effect the onset of RCFS.
期刊论文(56)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
和田英夫,他: "後天性溶血性貧血の治療における血漿交換・血漿論注療法" 日常診療と血液. 4. 61-66 (1994)
Hideo Wada 等人:“治疗获得性溶血性贫血的血浆交换/自行治疗”日常实践和血液。 4. 61-66 (1994)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Wakita Y.,et al: "Trcatnert of throabetic thecorhocytoperic purpara with plasoin excharge" Jpn.J.Apheresis. 14. (1995)46-47
Wakita Y.等人:“Trcatnert of throabetic thecorhocytoperic purpara with plasoin excharge”Jpn.J.Apheresis。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Wakita Y,et al: "Treatment of thrombotic thrombocytopenic purpura with plasma exchange." Jpn J Aphersis. 14(1). 46-47 (1995)
Wakita Y 等人:“用血浆置换治疗血栓性血小板减少性紫癜。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Wakita Y.,et al: "Trcatnert of throabetic thecorhocytoperic purpara with plasoin excharge" Jpn.J.Apheresis. 14. (1995)
Wakita Y.等人:“Trcatnert of throabetic thecorhocytoperic purpara with plasoin excharge”Jpn.J.Apheresis。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Wada H.,et al.: "Tissue factor expression in endothelial cells in health and disease." Blood Ceas.Fibrinol. 6(Supplerent). S26-S31 (1995)
Wada H.,et al.:“健康和疾病中内皮细胞中的组织因子表达。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 28 条
Monitoring for anticoagulant therapy and mechanism for anticoagulant
-
批准号:24590692
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.41万
-
财政年份:2012
-
负责人:WADA Hideo
-
依托单位:
Study on early diagnosis of hypercoagulable state and mechanism for the onset in thrombosis
-
批准号:21590623
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.16万
-
财政年份:2009
-
负责人:WADA Hideo
-
依托单位:
Analysis of mechanism on enhancement of fibrinolysis as biological defense
-
批准号:13470519
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$6.46万
-
财政年份:2001
-
负责人:WADA Hideo
-
依托单位:
Identification of antigen for cause of ITP by the new molecular biological method (SEREX)
-
批准号:10670943
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$0.64万
-
财政年份:1998
-
负责人:WADA Hideo
-
依托单位:
国内基金
海外基金
登录
查看更多内容
抗志贺毒素纳米抗体胞内递送通过靶向Gb3受体对STEC-HUS所致肾损伤的治疗作用及机制研究
-
批准号:82300808
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:刘杨
-
依托单位:
新型多肽及修饰体抗感染性HUS活性及其作用机制研究
-
批准号:81072677
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:王慧
-
依托单位:
细胞周期调控蛋白Rad9-Rad1-Hus1复合物的晶体结构研究
-
批准号:30770435
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2007
-
负责人:江涛
-
依托单位:
p21和Hus1在介导辐射损伤信号产生与传导以及旁效应中的作用研究
-
批准号:30770504
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2007
-
负责人:吴李君
-
依托单位:
细胞周期调控蛋白复合体Rad9-Rad1-Hus1在维护基因组稳定性中的作用
-
批准号:30530180
-
项目类别:重点项目
-
资助金额:140.0万元
-
批准年份:2005
-
负责人:杭海英
-
依托单位:
Hus1基因的抑突变和抑癌功能研究
-
批准号:30470373
-
项目类别:面上项目
-
资助金额:23.0万元
-
批准年份:2004
-
负责人:杭海英
-
依托单位:
大肠癌相关基因HUS20428编码结构功能及突变研究
-
批准号:39870821
-
项目类别:面上项目
-
资助金额:13.0万元
-
批准年份:1998
-
负责人:邓甬川
-
依托单位: